AQST — Aquestive Therapeutics Balance Sheet
0.000.00%
Last trade - 00:00
- $440.73m
- $380.89m
- $50.58m
- 27
- 27
- 73
- 38
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Cash and Equivalents | |||||
Cash and Short Term Investments | 49.3 | 31.8 | 28 | 27.3 | 23.9 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 13.1 | 6.96 | 12.1 | 4.7 | 8.47 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Current Assets | 68.3 | 44.6 | 47.3 | 39.9 | 41 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 9.73 | 10.3 | 7.78 | 9.3 | 9.74 |
Net Intangible Assets | |||||
Long Term Notes Receivable | |||||
Other Long Term Assets | |||||
Total Assets | 78.5 | 62.9 | 62 | 57.1 | 57.4 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 18.6 | 21.1 | 22 | 39.5 | 18.3 |
Long Term Debt | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Total Other Liabilities | |||||
Total Liabilities | 84.6 | 111 | 144 | 176 | 164 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Total Equity | -6.12 | -48.5 | -82.1 | -119 | -106 |
Total Liabilities & Shareholders' Equity | 78.5 | 62.9 | 62 | 57.1 | 57.4 |
Total Common Shares Outstanding |